Publication: Expression of the inhibitor of apoptosis protein survivin in benign meningiomas
| dc.contributor.author | Asha Das | en_US |
| dc.contributor.author | Wan Loo Tan | en_US |
| dc.contributor.author | Duncan R. Smith | en_US |
| dc.contributor.other | National Neuroscience Institute of Singapore | en_US |
| dc.contributor.other | Mahidol University | en_US |
| dc.date.accessioned | 2018-07-24T03:20:16Z | |
| dc.date.available | 2018-07-24T03:20:16Z | |
| dc.date.issued | 2003-04-25 | en_US |
| dc.description.abstract | Survivin is a recently characterised inhibitor of apoptosis protein that has been implicated in the pathogenesis of several types of solid organ cancer. This study sought to describe the expression of survivin in a cohort of 90 benign meningiomas, together with the pattern of expression of other genes involved in the apoptotic process, namely bax and bcl2. Survivin expression was noted in 94% (85/90) of samples and was not correlated with the expression of either bax or bcl2 or with clinicopathological factors. © 2003 Elsevier Science Ltd. All rights reserved. | en_US |
| dc.identifier.citation | Cancer Letters. Vol.193, No.2 (2003), 217-223 | en_US |
| dc.identifier.doi | 10.1016/S0304-3835(02)00741-3 | en_US |
| dc.identifier.issn | 03043835 | en_US |
| dc.identifier.other | 2-s2.0-0037466467 | en_US |
| dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/20741 | |
| dc.rights | Mahidol University | en_US |
| dc.rights.holder | SCOPUS | en_US |
| dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0037466467&origin=inward | en_US |
| dc.subject | Biochemistry, Genetics and Molecular Biology | en_US |
| dc.title | Expression of the inhibitor of apoptosis protein survivin in benign meningiomas | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0037466467&origin=inward | en_US |